Patents by Inventor Chander Shekher Celly

Chander Shekher Celly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted piperazines as CB1 antagonists
    Patent number: 8623873
    Abstract: Compounds of Formula (I): or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: January 7, 2014
    Assignee: Intervet Inc.
    Inventors: Eric J. Gilbert, Michael W. Miller, Jack D. Scott, Duane Eugene DeMong, Andrew Stamford, William J. Greenlee, Chander Shekher Celly
  • Carbonates of fenicol antibiotics
    Patent number: 8119667
    Abstract: Novel fenicol compounds having useful properties as antibiotic prodrugs, are provided, together with methods of making and using these new compounds.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: February 21, 2012
    Assignee: Schering-Plough Animal Health Corporation
    Inventors: Tomasz W. Glinka, Dale Edward Shuster, Chander Shekher Celly, Robert D. Simmons, Jason Zhang
  • SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS
    Publication number: 20100286160
    Abstract: Compounds of Formula (I): or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
    Type: Application
    Filed: June 25, 2008
    Publication date: November 11, 2010
    Inventors: Eric J. Gilbert, William J. Greenlee, Sarah Wei Li, Michael W. Miller, Jack D. Scott, Adrew Stamford, Chander Shekher Celly
  • SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS
    Publication number: 20100249144
    Abstract: Compounds of Formula (I) or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
    Type: Application
    Filed: June 25, 2008
    Publication date: September 30, 2010
    Inventors: Duane Eugene Demong, Michael W. Miller, Eric J. Gilbert, Jack D. Scott, Andrew Stamford, William J. Greenlee, Chander Shekher Celly
  • Substituted Piperazines as CB1 Antagonists
    Publication number: 20090105208
    Abstract: Compounds of Formula (I): or pharmaceutically acceptable salts, solvates, or esters thereof, are useful in treating diseases or conditions mediated by CB1 receptors, such as metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, addiction (e.g., smoking cessation), gastrointestinal disorders, and cardiovascular conditions.
    Type: Application
    Filed: June 25, 2008
    Publication date: April 23, 2009
    Inventors: Eric J. Gilbert, Michael W. Miller, Jack D. Scott, Duane Eugene DeMong, Andrew Stamford, William J. Greenlee, Chander Shekher Celly
  • CARBONATES OF FENICOL ANTIBIOTICS
    Publication number: 20070155799
    Abstract: Novel fenicol compounds having useful properties as antibiotic prodrugs, are provided, together with methods of making and using these new compounds.
    Type: Application
    Filed: December 18, 2006
    Publication date: July 5, 2007
    Inventors: Tomasz W. Glinka, Dale Edward Shuster, Chander Shekher Celly, Robert D. Simmons, Jason Zhang